Elevation of plasma-prolactin by monoamine-oxidase inhibitors.
Plasma-prolactin levels doubled in depressive patients treated with the monoamine-oxidase inhibitors, clorgyline and pargyline. The absence of significant changes in plasma-cortisol in the same patients suggests that the increases in prolactin are not attributable to non-specific effects of stress.
D003010:Clorgyline / Q000494:pharmacology* / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D010293:Pargyline / Q000494:pharmacology* / Q000627:therapeutic use; D010919:Placebos; D011388:Prolactin / Q000097:blood*; D011437:Propylamines / Q000494:pharmacology*
D010919:Placebos; D011437:Propylamines; D011388:Prolactin; D010293:Pargyline; D003010:Clorgyline; D006854:Hydrocortisone